Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients

6th July 2020 Uncategorised 0

Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
kblankenship
Mon, 07/06/2020 – 09:20




More: Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Source: fierce